A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97

John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
Times Cited: 1030

List of shared articles

Times cited

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Zachary T Bloomgarden, Lawrence Blonde, Alan J Garber, Carol H Wysham. Endocr Pract 2012

Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes.
Marie-Christine Dubé, Martin D'Amours, S John Weisnagel. Diabetes Obes Metab 2018

Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016

How to fight obesity with antidiabetic drugs: targeting gut or kidney?
M Baretić, R Troskot. Minerva Endocrinol 2015

Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016

Glucagon-like peptide-1 analogues: An overview.
Vishal Gupta. Indian J Endocrinol Metab 2013

The potential of incretin-based therapies in type 1 diabetes.
Chen S Suen, Paul Burn. Drug Discov Today 2012

Recent advances in incretin-based therapies.
David Russell-Jones, Stephen Gough. Clin Endocrinol (Oxf) 2012

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016